Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Once-daily COPD portfolio data from Novartis presented at European Respiratory Society (ERS) Annual Congress

Novartis announced new analyses of data for once-daily Ultibro® Breezhaler® (investigational QVA149 - indacaterol 85 mcg/glycopyrronium 43 mcg delivered dose, equivalent to 110 mcg/50 mcg metered dose per capsule), which showed significant improvements in lung function, shortness of breath and health-related quality of life for chronic obstructive pulmonary disease (COPD) patients versus all comparators1,2. These data were part of 39 respiratory abstracts presented at the European Respiratory Society (ERS) Annual Congress in Barcelona, Spain.

9 Sep 2013

McNeil Recalls 200,000 bottles of Concentrated MOTRIN Infants Drops Original Berry Flavor 1/2 fl oz

McNeil Consumer Healthcare Division of McNEIL-PPC, Inc. ("McNeil") is voluntarily recalling at the retail level three lots, approximately 200,000 bottles, of Concentrated MOTRIN® Infants' Drops Original Berry Flavor 1/2 fl oz bottles distributed in the United States.

7 Sep 2013

PaxVax commences phase 3 clinical trial for single-dose oral cholera vaccine candidate

PaxVax Inc, which develops and commercializes innovative vaccines against infectious diseases in a socially responsible manner, today announced that it has commenced its Phase 3 clinical trial program for its single-dose oral cholera vaccine candidate, PXVX0200 (also known as CVD 103-HgR). Approximately 3,000 participants will be enrolled in this pivotal program, which is comprised of cholera challenge, safety, and immunogenicity studies.

7 Sep 2013

Sanofi To Commercialize Pozen Proton Pump Inhibitor/Aspirin Product

...

6 Sep 2013

Sanofi To Commercialize Pozen Proton Pump Inhibitor/Aspirin Product

...

5 Sep 2013

Patheon's Q3 2013 revenues increase 30.4% to $265.7 million

Patheon Inc., a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry, with recently acquired proprietary products, announced today fiscal 2013 third quarter results.

5 Sep 2013

Sanofi, POZEN ink license agreement to commercialize PA8140 and PA32540 tablets in US

Sanofi US and POZEN Inc. announced the signing of an exclusive license agreement for the commercialization of POZEN's proprietary, investigational, coordinated-delivery tablets combining immediate-release omeprazole, a proton pump inhibitor, and enteric-coated aspirin in a single tablet ("PA"), PA8140 and PA32540.

5 Sep 2013

Dakota Laboratories banned from manufacturing and distributing drugs

Dakota Laboratories LLC and its president, Charles L. Voellinger, Sr., are prohibited from manufacturing and distributing drugs until they correct their ongoing violations of the drug manufacturing laws.

4 Sep 2013

Cangene Signs Up To $77M Contract Extension With CDC

...

3 Sep 2013

Cangene Inks Up To $77M Contract Extension With CDC

...

3 Sep 2013

Targeted Medical Pharma launches new division to manufacture and distribution dietary supplements

Targeted Medical Pharma, Inc., a biotechnology company that develops and distributes prescription medical foods to physicians and pharmacies, today announced the launch of a new division that will specialize in the manufacturing and distribution of a proprietary line of dietary supplements.

30 Aug 2013

UT finds way to blend passion for chemistry with ideals of environmental sustainability

A University of Texas at Arlington junior who found a way to blend a passion for chemistry with ideals of environmental sustainability is getting help from the U.S. Environmental Protection Agency to further his education and his research.

29 Aug 2013

Future of biomedical innovation depends on new trend for all players to work together for common goal

It's a long, expensive, risky road to turn a scientific breakthrough into a treatment that can help patients. Fewer organizations are trying to tackle the challenges alone, says a new paper from MIT researchers published August 28 in the journal Science Translational Medicine.

29 Aug 2013

Researchers develop ddPCR technology to quantify rejection biomarker in organ transplant injury

A recently reported blood test for the early detection of organ transplant injury could enable more timely therapeutic intervention in transplant patients and thus help to avoid longer term damage. As described by scientists at the University Medical Center G-ttingen and Chronix Biomedical, a molecular diagnostics company, the new method uses Bio-Rad Laboratories' Droplet Digital PCR (ddPCR-) technology to overcome the obstacles of earlier tests, which were both time-consuming and costly.

28 Aug 2013

Fluoride added to water supplies reduces tooth decay in children

Fluoride is a naturally occurring mineral in water and many foods. In addition, fluoride is intentionally added to the public water supplies, because it has been demonstrated that communities with fluoride added to their water supplies have significantly reduced incidence of tooth decay in children.

28 Aug 2013

2ml deep well plate launched by Porvair Sciences

Porvair Sciences has developed the first 96-well round deep well plate that genuinely delivers 2.00 ml liquid capacity / well in an automation compatible SLAS / ANSI footprint. The revolutionary "common wall" design provides a full 2ml round well, round bottom well within a 45mm height limit, thus ensuring full compatibility with most plate handling equipment.

From Porvair Sciences Limited 27 Aug 2013

Sangamo BioSciences signs definitive agreement to buy Ceregene

Sangamo BioSciences, Inc. announced that it signed a definitive agreement to acquire Ceregene, Inc., a privately held biotechnology company focused on developing adeno-associated virus gene therapies.

26 Aug 2013

TRS receives FDA approval for Cranial Bone Void Filler product

Tissue Regeneration Systems, Inc. today announced that it has received 510K approval from the U.S. Food and Drug Administration for its Cranial Bone Void Filler product, indicated for use in the repair of neurosurgical burr holes.

26 Aug 2013

FDA grants marketing approval for VALCHLOR gel for treatment of early stage CTCL

Ceptaris Therapeutics, Inc., a privately held, specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration has granted marketing approval for the orphan drug VALCHLOR (mechlorethamine) gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma in patients who have received prior skin-directed therapy.

26 Aug 2013

Novartis starts shipment of 2013-2014 seasonal influenza vaccines to US customers

Novartis announced today that it has begun shipment of its seasonal influenza vaccines to customers in the US market for the 2013-2014 season. Novartis plans to ship a minimum of 30 million doses of its influenza vaccines to the US market, including Fluvirin (Influenza Virus Vaccine), approved for use in people 4 years of age and older, and Flucelvax (Influenza Virus Vaccine), approved for use in adults 18 years of age and older.

22 Aug 2013

Manufacturing News and Research

Further Reading

Once-daily COPD portfolio data from Novartis presented at European Respiratory Society (ERS) Annual Congress

McNeil Recalls 200,000 bottles of Concentrated MOTRIN Infants Drops Original Berry Flavor 1/2 fl oz

PaxVax commences phase 3 clinical trial for single-dose oral cholera vaccine candidate

Sanofi To Commercialize Pozen Proton Pump Inhibitor/Aspirin Product

Sanofi To Commercialize Pozen Proton Pump Inhibitor/Aspirin Product

Patheon's Q3 2013 revenues increase 30.4% to $265.7 million

Sanofi, POZEN ink license agreement to commercialize PA8140 and PA32540 tablets in US

Dakota Laboratories banned from manufacturing and distributing drugs

Cangene Signs Up To $77M Contract Extension With CDC

Cangene Inks Up To $77M Contract Extension With CDC

Targeted Medical Pharma launches new division to manufacture and distribution dietary supplements

UT finds way to blend passion for chemistry with ideals of environmental sustainability

Future of biomedical innovation depends on new trend for all players to work together for common goal

Researchers develop ddPCR technology to quantify rejection biomarker in organ transplant injury

Fluoride added to water supplies reduces tooth decay in children

2ml deep well plate launched by Porvair Sciences

Sangamo BioSciences signs definitive agreement to buy Ceregene

TRS receives FDA approval for Cranial Bone Void Filler product

FDA grants marketing approval for VALCHLOR gel for treatment of early stage CTCL

Novartis starts shipment of 2013-2014 seasonal influenza vaccines to US customers

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy